The Clinical Evaluation of Drug Therapy in Parkinsonism and Models of Dysfunction of Brain Dopamine Systems in Animals

1986 ◽  
pp. 103-115
Author(s):  
J. R. Bianchine ◽  
R. D. Schwartz ◽  
C. W. Richard
1999 ◽  
pp. 421-430
Author(s):  
J.-Y. Reginster ◽  
B. Avouac ◽  
C. Gosset

1962 ◽  
Vol 5 (3) ◽  
pp. 308-323 ◽  
Author(s):  
Mindel C. Sheps

1955 ◽  
Vol 230 (2) ◽  
pp. 169-177 ◽  
Author(s):  
John L. Denney ◽  
Wallace G. Frasher ◽  
Donald D. Hoytt

1988 ◽  
Vol 16 (3) ◽  
pp. 210-215 ◽  
Author(s):  
C. H. Anyanwu ◽  
B. U. O. Umeh

This study investigated the effects of clavulanate-potentiated amoxycillin in the management of moderate to severe respiratory tract infections. A total of 34 patients aged 10–70 years were studied to establish the clinical and bacterial efficacy of treatment and screened for unwanted effects and abnormal laboratory findings. Clavulanate-potentiated amoxycillin was given in dosages of 375 or 750 mg twice daily, orally, for a mean of 13 days (range 3–30 days). Patients were assessed at the end of 2 weeks and again on discharge from hospital (if later) for up to 6 months. Overall diminution in the number of symptoms was recorded at the end of the study; 78% of symptoms had disappeared after 2 weeks. The treatment proved highly effective in controlling respiratory tract infections in 94% of patients. The necessity for multiple drug therapy and parenteral administration was also avoided.


1984 ◽  
Vol 17 (6) ◽  
pp. 769-772 ◽  
Author(s):  
N Bellamy ◽  
E Grace ◽  
B Hanna ◽  
E Grant ◽  
P Tugwell ◽  
...  

1971 ◽  
Vol 10 (1) ◽  
pp. 9-15
Author(s):  
Shigeichi Sunahara

1983 ◽  
Vol 14 (4) ◽  
pp. 215-222 ◽  
Author(s):  
Sol Ribner ◽  
Laurence Becker ◽  
Sid Marks ◽  
Paul Kahn ◽  
Fred Wolfson

Sign in / Sign up

Export Citation Format

Share Document